Lisa M Ebert

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 22

Top Venues

Journal for immunotherapy of cancer

Clinical & translational immunology

Immunology and cell biology

Oncoimmunology

University of Adelaide (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Adelaide

Australia

PHD :: Immunology

University of Adelaide

Australia

BSC

Publications

Isabella A Revesz, Paul Joyce, Lisa M Ebert, Clive A Prestidge
Effective γδ T-cell clinical therapies: current limitations and future perspectives for cancer immunotherapy. Clinical & translational immunology 13 (2) (2024)
Wenbo Yu, Nga Th Truong, Ruhi Polara, Tessa Gargett, Melinda N Tea, Stuart M Pitson, Michaelia P Cockshell, Claudine S Bonder, Lisa M Ebert, Michael P Brown
Endogenous bystander killing mechanisms enhance the activity of novel FAP-specific CAR-T cells against glioblastoma. Clinical & translational immunology 13 (7) (2024)
Tessa Gargett, Lisa M Ebert
Striking an alliance between T cells and macrophages for enhanced cancer immunotherapy. Immunology and cell biology (2024)
Tessa Gargett, Nga T H Truong, Bryan Gardam, Wenbo Yu, Lisa M Ebert, Amy Johnson, Erica C F Yeo, Nicole L Wittwer, Gonzalo Tapia Rico, Jesikah Logan, Purany Sivaloganathan, Maria Collis, Andrew Ruszkiewicz, Michael P Brown
Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancers. Journal for immunotherapy of cancer 12 (5) (2024)
Leesa Lertsumitkul, Melinda Iliopoulos, Stacie S Wang, Sarah J McArthur, Lisa M Ebert, Alexander J Davenport, Raelene Endersby, Jordan R Hansford, Katharine J Drummond, Ryan S Cross, Misty R Jenkins
EphA3-targeted chimeric antigen receptor T cells are effective in glioma and generate curative memory T cell responses. Journal for immunotherapy of cancer 12 (8) (2024)
Leesa Lertsumitkul, Melinda Iliopoulos, Stacie S Wang, Sarah J McArthur, Lisa M Ebert, Alexander J Davenport, Raelene Endersby, Jordan R Hansford, Katharine J Drummond, Ryan S Cross, Misty R Jenkins
EphA3-targeted chimeric antigen receptor T cells are effective in glioma and generate curative memory T cell responses. Journal for immunotherapy of cancer 12 (8) (2024)
Tessa Gargett, Nga T H Truong, Bryan Gardam, Wenbo Yu, Lisa M Ebert, Amy Johnson, Erica C F Yeo, Nicole L Wittwer, Gonzalo Tapia Rico, Jesikah Logan, Purany Sivaloganathan, Maria Collis, Andrew Ruszkiewicz, Michael P Brown
Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancers. Journal for immunotherapy of cancer 12 (5) (2024)
Wenbo Yu, Nga Th Truong, Ruhi Polara, Tessa Gargett, Melinda N Tea, Stuart M Pitson, Michaelia P Cockshell, Claudine S Bonder, Lisa M Ebert, Michael P Brown
Endogenous bystander killing mechanisms enhance the activity of novel FAP-specific CAR-T cells against glioblastoma. Clinical & translational immunology 13 (7) (2024)
Tessa Gargett, Nga T H Truong, Bryan Gardam, Wenbo Yu, Lisa M Ebert, Amy Johnson, Erica C F Yeo, Nicole L Wittwer, Gonzalo Tapia Rico, Jesikah Logan, Purany Sivaloganathan, Maria Collis, Andrew Ruszkiewicz, Michael P Brown
Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancers. Journal for immunotherapy of cancer 12 (5) (2024)
Leesa Lertsumitkul, Melinda Iliopoulos, Stacie S Wang, Sarah J McArthur, Lisa M Ebert, Alexander J Davenport, Raelene Endersby, Jordan R Hansford, Katharine J Drummond, Ryan S Cross, Misty R Jenkins
EphA3-targeted chimeric antigen receptor T cells are effective in glioma and generate curative memory T cell responses. Journal for immunotherapy of cancer 12 (8) (2024)
Isabella A Revesz, Paul Joyce, Lisa M Ebert, Clive A Prestidge
Effective γδ T-cell clinical therapies: current limitations and future perspectives for cancer immunotherapy. Clinical & translational immunology 13 (2) (2024)
Tessa Gargett, Lisa M Ebert
Striking an alliance between T cells and macrophages for enhanced cancer immunotherapy. Immunology and cell biology 102 (7) (2024)
Snehlata Kumari, Rachael M Zemek, Umaimainthan Palendira, Lisa M Ebert
Celebrating 100 years of Immunology & Cell Biology - a special focus on the field of tumor immunology in Australia. Immunology and cell biology (2023)
Brett W Stringer, Manam Inushi De Silva, Zarina Greenberg, Alejandra Noreña Puerta, Robert J Adams, Bridget Milky, Michael Zabolocki, Mark van den Hurk, Lisa M Ebert, Christine Fairly Bishop, Simon J Conn, Ganessan Kichenadasse, Michael Z Michael, Rebecca J Ormsby, Santosh Poonoose, Cedric Bardy
Human cerebrospinal fluid affects chemoradiotherapy sensitivities in tumor cells from patients with glioblastoma. Science advances 9 (43) (2023)
Tessa Gargett, Lisa M Ebert, Nga T H Truong, Paris M Kollis, Kristyna Sedivakova, Wenbo Yu, Erica C F Yeo, Nicole L Wittwer, Briony L Gliddon, Melinda N Tea, Rebecca Ormsby, Santosh Poonnoose, Jake Nowicki, Orazio Vittorio, David S Ziegler, Stuart M Pitson, Michael P Brown
GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma. Journal for immunotherapy of cancer 10 (9) (2022)
Lih Y Tan, Michaelia P Cockshell, Eli Moore, Kay K Myo Min, Michael Ortiz, M Zahied Johan, Brenton Ebert, Andrew Ruszkiewicz, Michael P Brown, Lisa M Ebert, Claudine S Bonder
Vasculogenic mimicry structures in melanoma support the recruitment of monocytes. Oncoimmunology 11 (1) (2022)
Nga T H Truong, Tessa Gargett, Michael P Brown, Lisa M Ebert
Effects of Chemotherapy Agents on Circulating Leukocyte Populations: Potential Implications for the Success of CAR-T Cell Therapies. Cancers 13 (9) (2021)
Sakthi Lenin, Elise Ponthier, Kaitlin G Scheer, Erica C F Yeo, Melinda N Tea, Lisa M Ebert, Mariana Oksdath Mansilla, Santosh Poonoose, Ulrich Baumgartner, Bryan W Day, Rebecca J Ormsby, Stuart M Pitson, Guillermo A Gomez
A Drug Screening Pipeline Using 2D and 3D Patient-Derived In Vitro Models for Pre-Clinical Analysis of Therapy Response in Glioblastoma. International journal of molecular sciences 22 (9) (2021)
Erica C F Yeo, Michael P Brown, Tessa Gargett, Lisa M Ebert
The Role of Cytokines and Chemokines in Shaping the Immune Microenvironment of Glioblastoma: Implications for Immunotherapy. Cells 10 (3) (2021)
Amin Zadeh Shirazi, Eric Fornaciari, Narjes Sadat Bagherian, Lisa M Ebert, Barbara Koszyca, Guillermo A Gomez
DeepSurvNet: deep survival convolutional network for brain cancer survival rate classification based on histopathological images. Medical & biological engineering & computing 58 (5) (2020)
Lisa M Ebert, Wenbo Yu, Tessa Gargett, John Toubia, Paris M Kollis, Melinda N Tea, Brenton W Ebert, Cedric Bardy, Mark van den Hurk, Claudine S Bonder, Jim Manavis, Kathleen S Ensbey, Mariana Oksdath Mansilla, Kaitlin G Scheer, Sally L Perrin, Rebecca J Ormsby, Santosh Poonnoose, Barbara Koszyca, Stuart M Pitson, Bryan W Day, Guillermo A Gomez, Michael P Brown
Endothelial, pericyte and tumor cell expression in glioblastoma identifies fibroblast activation protein (FAP) as an excellent target for immunotherapy. Clinical & translational immunology 9 (10) (2020)
Lih Yin Tan, Carmela Martini, Zvi G Fridlender, Claudine S Bonder, Michael P Brown, Lisa M Ebert
Control of immune cell entry through the tumour vasculature: a missing link in optimising melanoma immunotherapy? Clinical & translational immunology 6 (3) (2017)

Lisa M Ebert.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Lisa M Ebert